For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03866382
Contact name
Steven Schmitt
Clinical trials study type
Clinical trials trial status
IRB number
1857033
Principal investigator
Ari Elman, MD
Clinical trials study number
A031702
Phone
443-849-3285
Clinical trials title (full)
Alliance A031702, A phase II study of Ipilimumab, CabOzantinib, and NIvolumab in rare genitourinary Cancers